The BIRD Foundation funds collaborative industrial R&D between U.S. and Israeli companies across healthcare IT, life sciences, medical technologies, AI and software, cybersecurity, advanced manufacturing, cleantech, energy, and agriculture. Projects must offer mutual benefit to both countries and be oriented toward commercialization rather than basic research.
Applicants partner as two unrelated companies ( one U.S.-registered, one Israeli ) and create an application together. Early consultation with the program and submission of an executive summary are required before a full proposal. To review the requirements and begin, click on the link here. Executive Summaries (using BIRD’s template) are due November 23, 2026.